Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings

Why It Matters

The presence of a prescription‑only drug in counterfeit supplements poses serious health risks and highlights vulnerabilities in supply‑chain oversight, prompting tighter industry safeguards.

Key Takeaways

• Counterfeit Green Lumber contains undeclared tadalafil.
• Authentic packs show lot number LOTGLU13101b1EXP0926.
• Employee diversion caused counterfeit distribution.
• FDA testing triggered company recall and termination.
• Consumers urged to stop use and report.

Pulse Analysis

The discovery of tadalafil—a prescription medication for erectile dysfunction—in counterfeit Green Lumber supplements underscores a growing threat of adulterated health products entering the market. FDA laboratory analysis identified the undeclared drug, prompting Green Lumber to issue a rapid consumer alert. Such incidents erode public trust and can lead to severe adverse events, especially when the hidden ingredient interacts with cardiovascular medications. By publicly detailing the lot number discrepancy, the company aims to empower consumers to differentiate genuine products from fakes.

Supply‑chain integrity has become a focal point for manufacturers after internal investigations revealed that a single employee misused legitimate packaging and customer data to distribute counterfeit goods. This breach illustrates how insider threats can bypass traditional quality controls, forcing firms to adopt multi‑layered authentication methods, such as serialized lot numbers and tamper‑evident seals. Industry analysts note that the incident may accelerate adoption of blockchain‑based traceability solutions, which provide immutable records of product provenance and can quickly flag anomalies before they reach consumers.

For consumers, the immediate priority is to verify the lot number LOTGLU13101b1EXP0926 on blister packs and discontinue any product lacking this identifier. Reporting suspected counterfeits to Green Lumber and the FDA’s MedWatch program helps authorities track distribution networks and prevent further exposure. Looking ahead, Green Lumber’s commitment to enhanced safeguards and cooperation with regulators signals a proactive stance that could restore confidence and set a benchmark for other supplement manufacturers confronting similar counterfeit challenges.